Page last updated: 2024-12-05

coroxon

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

coroxon: oxygen analog of coumaphos [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9453
CHEMBL ID1891727
SCHEMBL ID669657
MeSH IDM0050119

Synonyms (37)

Synonym
einecs 206-288-6
phosphoric acid, diethyl ester, ester with 3-chloro-7-hydroxy-4-methylcoumarin
o,o-di(2-chloroethyl)-7-(3-chloro-4-methylcoumarinyl)phosphate
coroxon
o,o-diethyl o-(3-chloro-4-methylcoumarin-7-yl) phosphate
brn 1266025
diethyl 3-chloro-4-methyl-7-coumarinyl phosphate
3-chloro-4-methyl-2-oxo-2h-1-benzopyran-7-yl diethyl phosphate
3-chloro-4-methyl-7-coumarinyl diethyl phosphate
coumarin, 3-chloro-7-hydroxy-4-methyl-, diethyl phosphate
NCGC00163950-01
(3-chloro-4-methyl-2-oxochromen-7-yl) diethyl phosphate
321-54-0
coralox
NCGC00163950-02
unii-fs49k9q80b
phosphoric acid, 3-chloro-4-methyl-2-oxo-2h-1-benzopyran-7-yl diethyl ester
fs49k9q80b ,
coumaphos-oxon
AKOS015965590
coumaphos oxon
o,o-diethyl o-(3-chloro-4-methyl-7-coumarinyl) phosphate
3-chloro-4-methylumbelliferone diethyl phosphate
coroxon [mi]
o,o-diethyl o-7-(3-chloro-4-methylumbelliferone) phosphate
3-chloro-7-hydroxy-4-methylcoumarin diethyl phosphate
phosphoric acid 3-chloro-4-methyl-2-oxo-2h-1-benzopyran-7-yl diethyl ester
SCHEMBL669657
CHEMBL1891727
FDYMERLIFOUIRZ-UHFFFAOYSA-N
3-chloro-4-methyl-2-oxo-2h-chromen-7-yl diethyl phosphate #
DTXSID1037513
AS-67630
J-018656
phosphoric acid 3-chloro-4-methyl-2-oxo-2h-chromen-7-yl ester diethyl ester
3-chloro-4-methyl-2-oxo-2h-chromen-7-yl diethyl phosphate
Q27278165
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
pregnane X nuclear receptorHomo sapiens (human)Potency44.66840.005428.02631,258.9301AID720659
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency17.03900.001019.414170.9645AID588536; AID588537
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency44.66840.010039.53711,122.0200AID588545
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (40.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.64

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.64 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.64)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]